A citation-based method for searching scientific literature

Geraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, Andrea Regier Voth, Ralph E Parchment, Alice P Chen, James H Doroshow. Onco Targets Ther 2022
Times Cited: 4







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Therapeutic Targeting of DNA Damage Response in Cancer.
Wonyoung Choi, Eun Sook Lee. Int J Mol Sci 2022
11
50

Mechanisms of PARP inhibitor sensitivity and resistance.
Alan D D'Andrea. DNA Repair (Amst) 2018
219
50

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.
Elizabeth M Swisher, Kevin K Lin, Amit M Oza, Clare L Scott, Heidi Giordano, James Sun, Gottfried E Konecny, Robert L Coleman, Anna V Tinker, David M O'Malley,[...]. Lancet Oncol 2017
735
50

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani,[...]. Cell 2017
25

New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment.
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Roberta Visconti, Aniello Cerrato, Angela Celetti. J Exp Clin Cancer Res 2019
42
25

Genomic Determinants of Homologous Recombination Deficiency across Human Cancers.
Tao Qing, Xinfeng Wang, Tomi Jun, Li Ding, Lajos Pusztai, Kuan-Lin Huang. Cancers (Basel) 2021
1
100

Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder Cancer.
Judit Börcsök, Miklos Diossy, Zsofia Sztupinszki, Aurel Prosz, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Dag R Stormoen, Helle Pappot, Istvan Csabai,[...]. Clin Cancer Res 2021
10
25

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer.
Thomas Powles, Danielle Carroll, Simon Chowdhury, Gwenaelle Gravis, Florence Joly, Joan Carles, Aude Fléchon, Pablo Maroto, Daniel Petrylak, Frédéric Rolland,[...]. Nat Med 2021
33
25

Inhibitors of PARP: Number crunching and structure gazing.
Johannes Rudolph, Karen Jung, Karolin Luger. Proc Natl Acad Sci U S A 2022
15
25

The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.
Brigida Anna Maiorano, Domenica Lorusso, Mauro Francesco Pio Maiorano, Davide Ciardiello, Paola Parrella, Antonio Petracca, Gennaro Cormio, Evaristo Maiello. Int J Mol Sci 2022
4
25

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
P Grivas, Y Loriot, R Morales-Barrera, M Y Teo, Y Zakharia, S Feyerabend, N J Vogelzang, E Grande, N Adra, A Alva,[...]. BMC Cancer 2021
16
25

PARP Inhibitors Resistance: Mechanisms and Perspectives.
Elena Giudice, Marica Gentile, Vanda Salutari, Caterina Ricci, Lucia Musacchio, Maria Vittoria Carbone, Viola Ghizzoni, Floriana Camarda, Francesca Tronconi, Camilla Nero,[...]. Cancers (Basel) 2022
7
25

Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU).
Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, Tu V Dao, Daniel Castellano, Jian-Ri Li, Som D Mukherjee, Kathryn Howells, Hannah Dry, Mark C Lanasa,[...]. J Clin Oncol 2023
2
50



Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, Flaminia Pedretti, Alejandro Moles-Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso,[...]. Cancer Res 2022
6
25

FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.
H Ishii, A Vecchione, Y Murakumo, G Baldassarre, S Numata, F Trapasso, H Alder, R Baffa, C M Croce. Proc Natl Acad Sci U S A 2001
83
25

The side effects of platinum-based chemotherapy drugs: a review for chemists.
Rabbab Oun, Yvonne E Moussa, Nial J Wheate. Dalton Trans 2018
558
25

A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.
Anguraj Sadanandam, Stephan Wullschleger, Costas A Lyssiotis, Carsten Grötzinger, Stefano Barbi, Samantha Bersani, Jan Körner, Ismael Wafy, Andrea Mafficini, Rita T Lawlor,[...]. Cancer Discov 2015
106
25

The testicular germ cell tumour transcriptome.
S Alagaratnam, G E Lind, S M Kraggerud, R A Lothe, R I Skotheim. Int J Androl 2011
37
25

Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer.
Shi-Ming Tu, Mehmet Asim Bilen, Kenneth R Hess, Russell R Broaddus, Scott Kopetz, Chongjuan Wei, Lance C Pagliaro, Jose A Karam, John F Ward, Christopher G Wood,[...]. Cancer 2016
29
25

KRAS: From undruggable to a druggable Cancer Target.
Dipesh Uprety, Alex A Adjei. Cancer Treat Rev 2020
74
25

Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression.
Benjamin J Schmiedel, Divya Singh, Ariel Madrigal, Alan G Valdovino-Gonzalez, Brandie M White, Jose Zapardiel-Gonzalo, Brendan Ha, Gokmen Altay, Jason A Greenbaum, Graham McVicker,[...]. Cell 2018
297
25

Salvage chemotherapy for patients with advanced pure seminoma.
Jacqueline Vuky, Satish K Tickoo, Joel Sheinfeld, Jennifer Bacik, Alison Amsterdam, Madhu Mazumdar, Victor Reuter, Dean F Bajorin, George J Bosl, Robert J Motzer. J Clin Oncol 2002
44
25

A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis.
Alain C Jung, Sylvie Job, Sonia Ledrappier, Christine Macabre, Joseph Abecassis, Aurélien de Reyniès, Bohdan Wasylyk. Clin Cancer Res 2013
39
25

Breast Cancer Treatment: A Review.
Adrienne G Waks, Eric P Winer. JAMA 2019
25

On the Origin of Testicular Germ Cell Tumors: From Gonocytes to Testicular Cancer.
Tiziano Baroni, Iva Arato, Francesca Mancuso, Riccardo Calafiore, Giovanni Luca. Front Endocrinol (Lausanne) 2019
22
25

Genomic Profile in a Non-Seminoma Testicular Germ-Cell Tumor Cohort Reveals a Potential Biomarker of Sensitivity to Platinum-Based Therapy.
Rodrigo González-Barrios, Nicolás Alcaraz, Michel Montalvo-Casimiro, Alejandra Cervera, Cristian Arriaga-Canon, Paulina Munguia-Garza, Diego Hinojosa-Ugarte, Nora Sobrevilla-Moreno, Karla Torres-Arciga, Julia Mendoza-Perez,[...]. Cancers (Basel) 2022
1
100

Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate.
Timothy J Peters, Michael J Buckley, Yunshun Chen, Gordon K Smyth, Christopher C Goodnow, Susan J Clark. Nucleic Acids Res 2021
5
25

Molecular profiling for precision cancer therapies.
Eoghan R Malone, Marc Oliva, Peter J B Sabatini, Tracy L Stockley, Lillian L Siu. Genome Med 2020
237
25

Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacy.
Bushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, Monika Guggemoos, Katja Gall, Carolin Prexler, Ilya Kazantsev, Alexandra Sipol, Lars Lindner, Michaela Nathrath,[...]. Oncotarget 2018
8
25

TCam-2 Cells Deficient for SOX2 and FOXA2 Are Blocked in Differentiation and Maintain a Seminoma-Like Cell Fate In Vivo.
Daniel Nettersheim, Saskia Vadder, Sina Jostes, Alena Heimsoeth, Hubert Schorle. Cancers (Basel) 2019
9
25

Emerging role of long non-coding RNAs in cisplatin resistance.
Yang Hu, Qiong-Ni Zhu, Jun-Li Deng, Zhi-Xing Li, Guo Wang, Yuan-Shan Zhu. Onco Targets Ther 2018
50
25


Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer.
R Escudero-Ávila, J D Rodríguez-Castaño, I Osman, F Fernandez, R Medina, B Vargas, M Japón-Rodríguez, P Sancho, B Perez-Valderrama, J M Praena-Fernández,[...]. Clin Transl Oncol 2019
8
25


Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic.
João Lobo, Ad J M Gillis, Carmen Jerónimo, Rui Henrique, Leendert H J Looijenga. Int J Mol Sci 2019
73
25

Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma.
Hisamitsu Takaya, Hidekatsu Nakai, Shiro Takamatsu, Masaki Mandai, Noriomi Matsumura. Sci Rep 2020
77
25


The Molecular Signatures Database (MSigDB) hallmark gene set collection.
Arthur Liberzon, Chet Birger, Helga Thorvaldsdóttir, Mahmoud Ghandi, Jill P Mesirov, Pablo Tamayo. Cell Syst 2015
25

A role for the p53 tumour suppressor in regulating the balance between homologous recombination and non-homologous end joining.
Sylvie Moureau, Janna Luessing, Emma Christina Harte, Muriel Voisin, Noel Francis Lowndes. Open Biol 2016
24
25

Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.
Henning Willers, Christopher G Azzoli, Wil L Santivasi, Fen Xia. Cancer J 2013
137
25

MPscore: A Novel Predictive and Prognostic Scoring for Progressive Meningioma.
Feili Liu, Jin Qian, Chenkai Ma. Cancers (Basel) 2021
6
25


Triple-negative breast cancer molecular subtyping and treatment progress.
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-Cang Yu. Breast Cancer Res 2020
409
25

Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors.
H Boer, J H Proost, J Nuver, S Bunskoek, J Q Gietema, B M Geubels, R Altena, N Zwart, S F Oosting, J M Vonk,[...]. Ann Oncol 2015
45
25

Genomic characteristics revealed by targeted exon sequencing of testicular germ cell tumors in Japanese men.
Takashi Matsumoto, Masaki Shiota, Takeshi Uchiumi, Shohei Ueda, Shigehiro Tsukahara, Takahiro Toshima, Shinya Matsumoto, Nozomi Noda, Masatoshi Eto, Dongchon Kang. Int J Urol 2021
5
25

Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Hui Shen, Juliann Shih, Daniel P Hollern, Linghua Wang, Reanne Bowlby, Satish K Tickoo, Vésteinn Thorsson, Andrew J Mungall, Yulia Newton, Apurva M Hegde,[...]. Cell Rep 2018
216
25

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
25

Differentiation of Human Induced Pluripotent or Embryonic Stem Cells Decreases the DNA Damage Repair by Homologous Recombination.
Kalpana Mujoo, Raj K Pandita, Anjana Tiwari, Vijay Charaka, Sharmistha Chakraborty, Dharmendra Kumar Singh, Shashank Hambarde, Walter N Hittelman, Nobuo Horikoshi, Clayton R Hunt,[...]. Stem Cell Reports 2017
23
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.